Clin2
NCT07792954Possibly a fitNot yet recruiting

Weekly study medicine for weight loss in Chinese adults

ObesityOverweight

Part of Hormones & metabolism clinical trials.

This trial tests a once-weekly medicine, PF-08653944, to help Chinese adults with overweight or obesity lose weight. It aims to see if the medicine is more effective than a placebo, and could offer a new treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a BMI of 28 or higher, or a BMI between 24 and 28 with at least one weight-related health condition (such as high blood pressure or high cholesterol).
  • If you have type 2 diabetes, your most recent blood sugar test (HbA1c) must be between 6.5% and 10.0%.
  • You have tried to lose weight through diet before but were not successful.
  • You have not had significant, unintentional weight loss or gain in the past 3 months (more than 5% of your body weight).
  • You do not have type 1 diabetes, a history of pancreatitis, or a personal or family history of certain thyroid conditions. You have not had weight-loss surgery recently and are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07595549Recruiting· Phase 3
Testing Berobenatide for Weight Loss in Overweight Adults

This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.

Canoga Park, California
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07790861Not yet recruiting· Phase 3
Study of an oral weight loss medication in Chinese adults with overweight or obesity

This trial tests an investigational oral medication to help Chinese adults with overweight or obesity, plus related health issues, lose weight. It focuses on improving weight loss and overall health in this group.

Chengdu
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07731139Not yet recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07503210Recruiting· Phase 3
Study of a new medicine to maintain weight loss

This study tests an investigational medicine to help people who have lost weight keep it off. It's for adults without diabetes who haven't used similar weight-loss drugs before.

Anniston, Alabama

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.